A highly expressed 81 kDa protein in immortalized mouse fibroblast: its proliferative function and identity with ezrin.

SC Kaul, Y Mitsui, Y Komatsu, RR Reddel, R Wadhwa - Oncogene, 1996 - europepmc.org
SC Kaul, Y Mitsui, Y Komatsu, RR Reddel, R Wadhwa
Oncogene, 1996europepmc.org
An 81 kDa protein was found to be highly expressed in spontaneously immortalized CD1-
ICR mouse fibroblasts, RS-4, as compared to normal fibroblasts. RS-4 cells have a reduced
serum requirement and exhibit multilayered growth in vitro but are not tumorigenic. The
protein was purified from RS-4 cell extracts and used to obtain a polyclonal antibody that
specifically immunoprecipitated an 81 kDa protein from cell lysates. Immunocloning of its
cDNA and sequence analysis revealed its identity with ezrin, an F-actin binding protein that …
An 81 kDa protein was found to be highly expressed in spontaneously immortalized CD1-ICR mouse fibroblasts, RS-4, as compared to normal fibroblasts. RS-4 cells have a reduced serum requirement and exhibit multilayered growth in vitro but are not tumorigenic. The protein was purified from RS-4 cell extracts and used to obtain a polyclonal antibody that specifically immunoprecipitated an 81 kDa protein from cell lysates. Immunocloning of its cDNA and sequence analysis revealed its identity with ezrin, an F-actin binding protein that is a component of the cortical cytoskeleton. Microinjection of the purified IgG fraction of the anti-p81 antiserum into the cytoplasm of RS-4 cells blocked their entry into S phase suggesting that the protein has a proliferative function. Immunostaining of normal mouse tissues showed that the expression of p81/ezrin was highest in proliferating cell populations. Unlike RS-4, NIH3T3 cells exhibit contact inhibition and express levels of p81/ezrin similar to those of normal fibroblasts. When NIH3T3 cells were transfected with p81/ezrin cDNA they lost contact inhibition and thus resembled RS-4 cells. The study demonstrates a proliferative function of p81/ezrin and suggests its involvement in pathways that negatively regulate contact inhibition.
europepmc.org